SANDS CHINA LTD Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.
金沙中國有限公司
(Incorporated in the Cayman Islands with limited liability)
(Stock Code: 1928)The board of directors (the "Board") of Sands China Ltd. (the "Company") is pleased to announce that Dr. Wong Ying Wai ("Dr. Wong"), the President and Chief Operating Officer of the Company, has been appointed as an executive director of the Company ("Executive Director") and a member of the Remuneration Committee and the Sands China Capital Expenditure Committee ("Capex Committee") of the Company with effect from January 22, 2016.
Biographical information of Dr. Wong includes the following:
Dr. Wong Ying Wai, aged 63, has been appointed as the President and Chief Operating Officer of the Company since November 1, 2015. He is also a director of various subsidiaries of the Company. Dr. Wong joined the Administrative Officer grade of the Hong Kong Government in 1975 and served in a number of key positions including Deputy Secretary for the Civil Service and Deputy Director - General of Industry. Dr. Wong joined the private sector in 1992 and has held top management positions in a number of Hong Kong listed companies in the property development and construction business sectors including Hsin Chong Construction Group Ltd., K. Wah International Holdings Limited, Henderson China Holdings Limited and the Shui On Group.
Dr. Wong started his political career at the national level when he was appointed as a member of The Basic Law Consultative Committee (1985-1990) by the Central People's Government of the People's Republic of China. He was subsequently appointed by The National People's Congress of the People's Republic of China (the "NPC") as a member of the Preliminary Working Committee for the Hong Kong Special Administrative Region (the "HKSAR") Preparatory Committee in 1993 and a member of the HKSAR Preparatory Committee in 1995, both bodies were responsible for the transitional policies and arrangements relating to the establishment of the HKSAR Government in 1997. Dr. Wong was a Deputy to the NPC during the period from 1997 to 2013.
Dr. Wong's public service continues through his participation in a number of councils and committees in Hong Kong. He is currently the Chairman of Hong Kong Arts Development Council, the Chairman of Standing Commission on Civil Service Salaries and Conditions of Service, the Chairman of The Hong Kong International Film Festival Society Limited, the Chairman of Hong Kong Baptist University Foundation, the Chairman of the Pacific Basin Economic Council Limited and the Chairman of Hong Kong Institute for Public Administration. He was appointed as the Vice Chairman of Hong Kong Film Development Council in April 2013. He was the Chairman of the Court and Council of the Hong Kong Baptist University during the period from 2007 to 2012.
For his long and distinguished public and community service, Dr. Wong was awarded the Silver Bauhinia Star and the Gold Bauhinia Star by the Government of the HKSAR in 2007 and 2015 respectively. Dr. Wong was conferred the degree of Doctor of Humanities honoris causa from Hong Kong Baptist University in November 2013, recognizing his outstanding professional achievements as well as his remarkable contributions to society. He was educated at Harvard University (MPA), University of Oxford, The University of Hong Kong (BSocSc) and The Chinese University of Hong Kong.
Dr. Wong is currently an Independent Non-Executive Director of Xinyi Glass Holdings Limited, a company listed on The Stock Exchange of Hong Kong Limited (the "Stock Exchange") (Stock code: 868). Dr. Wong was the Executive Director, Executive Chairman and Chief Executive Officer of Hsin Chong Construction Group Ltd., a company listed on the Stock Exchange (Stock code: 404), until November 1, 2015 and serves as the senior adviser to the Board of Hsin Chong Construction Group Ltd. subsequent to his resignation from the other positions mentioned above. He was also a Non-Executive Director and Chairman of Synergis Holdings Limited, a company listed on the Stock Exchange (Stock code: 2340), until December 11, 2015.
Dr. Wong is appointed as an Executive Director of the Company for an initial term of three years commencing from January 22, 2016. He is subject to retirement by rotation and re-election at the annual general meeting of the Company in accordance with the Articles of Association of the Company.
As at the date of this announcement, Dr. Wong has interest of 4,000,000 underlying shares in the Company and does not have any interest in the shares or underlying shares of Las Vegas Sands Corp. (an associated corporation of the Company) within the meaning of Part XV of the Securities and Futures Ordinance (the "SFO") as recorded in the register required to be kept under Section 352 of Part XV of the SFO or as otherwise notified to the Company and the Stock Exchange pursuant to the Model Code for Securities Transactions by Directors of Listed Issuers set out in Appendix 10 of the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited (the "Listing Rules").
Dr. Wong does not receive any director's fees/emoluments for services provided to the Company in his capacity as an Executive Director and a member of the Remuneration Committee and Capex Committee of the Company. As President and Chief Operating Officer of the Company, Dr. Wong receives emoluments of US$2,300,000 per annum, plus a discretionary bonus of up to US$1,500,000 per annum, in accordance with the service contract entered into between Dr. Wong and the Company. The emoluments of Dr. Wong are determined by the Board with reference to his duties and responsibilities with the Company and the Company's remuneration policy and are subject to review by the Remuneration Committee from time to time. His emoluments are covered by the service contract/letter of appointment issued by the Company and any subsequent revision approved by the Board.
Save as disclosed above, as at the date of this announcement, Dr. Wong (i) does not currently hold any other position with the Company and other members of the Company's group; (ii) does not have any relationship with any other directors, senior management, or substantial or controlling shareholders of the Company; (iii) has not held any directorship in the last three years in any public companies the securities of which are listed on any securities market in Hong Kong or overseas; and
(iv) does not have other major appointments and professional qualifications.
Save for the information disclosed above, there is no information of Dr. Wong that is discloseable pursuant to any of the requirements under Rules 13.51(2)(h) to 13.51(2)(v) of the Listing Rules, and there are no other matters relating to the appointment of Dr. Wong that need to be brought to the attention of the shareholders of the Company.
The Board would like to welcome Dr. Wong as a member of the Board.
By order of the Board
SANDS CHINA LTD. Dylan James WilliamsCompany Secretary
Macao, January 22, 2016
As at the date of this announcement, the directors of the Company are:
Executive Directors: Sheldon Gary Adelson Wong Ying Wai
Toh Hup Hock
Non-Executive Directors: Robert Glen Goldstein Michael Alan Leven Charles Daniel Forman
Independent Non-Executive Directors:
Iain Ferguson Bruce Chiang Yun
David Muir Turnbull Victor Patrick Hoog Antink Steven Zygmunt Strasser
In case of any inconsistency between the English version and the Chinese version of this announcement, the English version shall prevail.
Sands China Ltd. issued this content on 2016-01-22 and is solely responsible for the information contained herein. Distributed by Public, unedited and unaltered, on 2016-01-22 04:44:17 UTC
Original Document: http://media.corporate-ir.net/media_files/IROL/23/233498/2016/1_Eng.pdf
